Company
eMed
eMed publishes brand semaglutide at $149.99 a month — Prescription medication (paid only if approved).
Published by Treatment Registry · Latest research
- 1 program
- 1 identified molecule
- 1 reading
Read from emed.com; latest program check September 2026. Individual programs and sources may have earlier verification dates.
Go to eMed
We earn nothing from this link. It opens eMed's website without a paid referral.
What it costs
first month, including required fees on record · ◯ $149.99 advertised · Prescription medication (paid only if approved)
Terms
- Membership
Required, $149.99 per month. eMed's Membership Fee $149.99 Per month
Evidence: September 2026
- States
Not disclosed
Evidence: September 2026
Not yet checked: pharmacy and consultation fee.
Programs
Notes
Pricing details, service terms and questions to confirm before enrolling.
September 2026
- 1. This is the clearest example of the two-fee trap the brief warns about, except eMed discloses BOTH figures separately on the same pricing block: 'Application & Screening $49 One-time fee', then 'Prescription Medication From $149.99 Per month (Paid only if approved)', then, as its own separate line, 'eMed's Membership Fee $149.99 Per month.' So a member on the medication pays roughly $49 once plus $149.99/mo for the drug plus another $149.99/mo membership fee — total ~$300/mo, not $149.99. Medication is Wegovy (brand semaglutide), offered as both the injection pen and a newly launched once-daily Wegovy pill (oral); no separate price is shown for the pill. No cancellation/subscription-termination language was found on any crawled page — only a no-returns/no-refunds policy for dispensed products.
Understand the terms
- Required membership fees
See how a separate membership changes the amount you pay.
Before you act
Cite this
Treatment Registry. (2026). eMed: recorded programs and prices. Last verified September 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/emed